KPTI fundamentals
Key facts
Market capitalization36.61 MUSD
Basic EPS (TTM)−9.42USD
Founded2008
CEORichard A. Paulson
Websitekaryopharm.com
About
Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
−180%
−120%
−60%
0%
60%
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
−50.00 M
−25.00 M
0.00
25.00 M
50.00 M
Revenue
Net income
Net margin %
Revenue breakdown
Revenue streams and regions a business earns money from
Estimates
Revenue and Earnings forecasts and estimates accuracy
Dividends
Dividend yield, history and sustainability
KPTI does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company